400 South Technology Drive, Central Islip, NY 11722 United States
Company Description
Renejix is the leading end to end CDMO accelerator for small molecule oral dosage forms at a competitive price. We have produced over 200 FDFs, 5+ billion dosages annually, and have a staff of ~500 employees. Take your molecules from concept to commercialization in record time by cutting 20 weeks off early and late phase timelines!